NAD+ delivery methods: what the science says vs. TikTok

What's this video probably claiming?

A creator comparing NAD+ injections, IV infusions, and oral supplements is almost certainly making the case that delivery method determines effectiveness, with injections or infusions positioned as superior to capsules. The framing likely goes something like: oral NAD+ gets destroyed in the gut, IVs flood your cells with the real stuff, and injections split the difference. You'll probably hear words like "bioavailability," "cellular energy," and "anti-aging" used with a confidence that isn't quite matched by the clinical literature. The hashtag pairing of #nad and #antiaging is doing a lot of heavy lifting here. NAD+ precursors have genuine biological plausibility, but the leap from "NAD declines with age" to "infusing it reverses aging" is a significant one that this kind of video rarely examines critically.

What does the science actually show?

The honest answer is that NAD+ research is promising but messy. Oral precursors like NMN and NR do raise blood NAD+ levels. Martens et al. (2020, Nature Metabolism) showed that 1,000 mg/day of NMN over 10 weeks elevated NAD+ in skeletal muscle of older adults. Airhart et al. (2017, PLOS ONE) found NR at 1,000 mg/day raised whole-blood NAD+ by roughly 2.7-fold versus placebo. IV NAD+ does bypass gut absorption entirely, and pharmacokinetic data confirm faster plasma spikes, but whether those spikes translate to meaningful intracellular NAD+ repletion in healthy people, rather than just sick ones, is genuinely unclear. A 2023 review in Cell Metabolism (Covarrubias et al.) noted that most dramatic NAD+ benefits in animal models have not replicated cleanly in human trials at equivalent doses. That's not a minor footnote.

Where does the social media noise diverge from clinical reality?

The biggest divergence is the certainty. TikTok NAD+ content treats delivery-method hierarchy as settled science. It isn't. IV infusions are expensive, require clinical supervision, and the controlled trial data specifically comparing IV to oral in healthy humans is thin. The claim that oral NAD+ is essentially useless ignores that NR and NMN are not the same as oral NAD+, which does have poor bioavailability, but their precursors have different absorption pathways entirely. Subcutaneous NAD+ injection data in humans is even sparser than IV data. The anti-aging framing is where things get genuinely reckless. Sirtuins, longevity genes, mitochondrial repair: these are real mechanisms being studied, but no human trial has demonstrated that any NAD+ delivery method extends lifespan or reverses measurable aging in otherwise healthy adults. Claiming otherwise is marketing dressed as biology.

What should you actually know?

NAD+ precursor supplementation is not snake oil, but it is also not a proven anti-aging intervention in healthy people. If you have a documented NAD+ deficiency or a condition where NAD+ metabolism is genuinely impaired, the conversation changes. For everyone else, the data supports modest, real increases in circulating NAD+ from oral precursors, with functional benefits that remain under investigation. IV infusions carry real costs and procedural risks, including flushing, nausea, and in rare cases more serious reactions, that content creators rarely mention. If you are considering any NAD+ protocol, that conversation belongs with a licensed clinician who has reviewed your labs, not a TikTok comparison video. FormBlends providers can assess whether NAD+ therapy is appropriate for your specific situation and which delivery approach, if any, makes clinical sense for you.